期刊
VIRUSES-BASEL
卷 13, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/v13050774
关键词
fludarabine; Zika virus; Severe fever with thrombocytopenia syndrome virus; Enterovirus A71; antiviral drugs
类别
资金
- Natural Science Foundation of Jiangsu Province of China [BK20190307]
- National Natural Science Foundation of China [81971923]
This study demonstrates that fludarabine effectively inhibits RNA virus infections with low cytotoxicity, suggesting its potential development as a broad-spectrum anti-RNA virus therapeutic agent.
Viral infections are one of the leading causes in human mortality and disease. Broad-spectrum antiviral drugs are a powerful weapon against new and re-emerging viruses. However, viral resistance to existing broad-spectrum antivirals remains a challenge, which demands development of new broad-spectrum therapeutics. In this report, we showed that fludarabine, a fluorinated purine analogue, effectively inhibited infection of RNA viruses, including Zika virus, Severe fever with thrombocytopenia syndrome virus, and Enterovirus A71, with all IC50 values below 1 mu M in Vero, BHK21, U251 MG, and HMC3 cells. We observed that fludarabine has shown cytotoxicity to these cells only at high doses indicating it could be safe for future clinical use if approved. In conclusion, this study suggests that fludarabine could be developed as a potential broad-spectrum anti-RNA virus therapeutic agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据